KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Charles River Laboratories International (CRL) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $85.2 million.

  • Charles River Laboratories International's Accumulated Depreciation & Amortization fell 344.0% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.2 million, marking a year-over-year decrease of 344.0%. This contributed to the annual value of $361.7 million for FY2024, which is 1515.87% up from last year.
  • Latest data reveals that Charles River Laboratories International reported Accumulated Depreciation & Amortization of $85.2 million as of Q3 2025, which was down 344.0% from $119.5 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Accumulated Depreciation & Amortization high stood at $361.7 million for Q4 2024, and its period low was $85.2 million during Q3 2025.
  • For the 5-year period, Charles River Laboratories International's Accumulated Depreciation & Amortization averaged around $183.0 million, with its median value being $119.9 million (2025).
  • Data for Charles River Laboratories International's Accumulated Depreciation & Amortization shows a peak YoY increase of 4101.25% (in 2025) and a maximum YoY decrease of 344.0% (in 2025) over the last 5 years.
  • Charles River Laboratories International's Accumulated Depreciation & Amortization (Quarter) stood at $265.5 million in 2021, then increased by 14.43% to $303.9 million in 2022, then rose by 3.37% to $314.1 million in 2023, then rose by 15.16% to $361.7 million in 2024, then tumbled by 76.46% to $85.2 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $85.2 million for Q3 2025, versus $119.5 million for Q2 2025 and $120.4 million for Q1 2025.